MedTrace Logo

A Prospective, Randomized, No-treatment Controlled, Evaluator-blinded Clinical Trial to Evaluate the Efficacy and Safety of Polycaprolactone Microspherical Injectable to Improve Forehead Contour

NCT06380972 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2025-04-29

No results posted yet for this study

Summary

A Prospective, Multicenter, Randomized, No-treatment-controlled, Evaluator-blinded, Superiority Clinical Trial to Evaluate the Efficacy and Safety of Polycaprolactone Based Facial Injectable to Improve Forehead Contour

Conditions

  • Forehead Contouring

Interventions

DEVICE

Polycaprolactone (PCL) Based Facial Injectable

Polycaprolactone (PCL) Based Facial Injectable

Sponsors & Collaborators

  • AQTIS Medical B.V.

    lead OTHER

Principal Investigators

  • SHENGKANG LUO · Guangdong Second People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2025-09-30
Completion
2025-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06380972 on ClinicalTrials.gov